Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer.


Journal

NPJ precision oncology
ISSN: 2397-768X
Titre abrégé: NPJ Precis Oncol
Pays: England
ID NLM: 101708166

Informations de publication

Date de publication:
02 Mar 2023
Historique:
received: 22 07 2022
accepted: 07 02 2023
entrez: 2 3 2023
pubmed: 3 3 2023
medline: 3 3 2023
Statut: epublish

Résumé

We performed a prospective study of circulating immune cell changes after stereotactic body radiotherapy (SBRT) in 50 early-stage NSCLC patients. We found no significant increase in CD8

Identifiants

pubmed: 36864234
doi: 10.1038/s41698-023-00358-z
pii: 10.1038/s41698-023-00358-z
pmc: PMC9981559
doi:

Types de publication

Journal Article

Langues

eng

Pagination

24

Informations de copyright

© 2023. The Author(s).

Références

Am J Respir Crit Care Med. 2018 Sep 15;198(6):777-787
pubmed: 29617574
J Clin Oncol. 2006 Oct 20;24(30):4833-9
pubmed: 17050868
J Thorac Oncol. 2018 Nov;13(11):1727-1732
pubmed: 30056162
Front Immunol. 2018 Mar 19;9:547
pubmed: 29616038
Int J Mol Sci. 2018 Dec 09;19(12):
pubmed: 30544863
PLoS One. 2020 Nov 30;15(11):e0241505
pubmed: 33253196
Nat Commun. 2017 Jun 09;8:15618
pubmed: 28598415
Trends Immunol. 2015 Apr;36(4):265-76
pubmed: 25797516
Clin Cancer Res. 2009 Sep 1;15(17):5379-88
pubmed: 19706802
Strahlenther Onkol. 2014 Jan;190(1):26-33
pubmed: 24052011
Nature. 2017 May 4;545(7652):60-65
pubmed: 28397821
Radiother Oncol. 2016 Aug;120(2):185-94
pubmed: 27495145
Nat Med. 2016 Apr;22(4):433-8
pubmed: 26901407
Nat Immunol. 2011 Jun;12(6):492-9
pubmed: 21739672
Nat Immunol. 2009 Jan;10(1):29-37
pubmed: 19043418
Nat Rev Cancer. 2016 May;16(5):275-87
pubmed: 27079802
J Clin Oncol. 2019 May 20;37(15):1316-1325
pubmed: 30943123
Radiother Oncol. 2020 Jul;148:82-88
pubmed: 32339780
Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):571-9
pubmed: 26867885
Nat Cancer. 2022 Dec;3(12):1498-1512
pubmed: 36443406
Nat Cancer. 2022 Nov;3(11):1300-1317
pubmed: 36434392
Clin Cancer Res. 2018 Oct 15;24(20):5058-5071
pubmed: 29898992
Cancer Immunol Immunother. 2020 Sep;69(9):1823-1832
pubmed: 32350591
J Clin Invest. 2019 Nov 1;129(11):4992-5004
pubmed: 31609250
Transl Lung Cancer Res. 2019 Feb;8(1):107-115
pubmed: 30788240
Eur J Cancer. 2021 Jan;143:113-126
pubmed: 33302114
Br J Radiol. 2015 Jul;88(1051):20150036
pubmed: 25873481
Front Oncol. 2019 Nov 12;9:1219
pubmed: 31799188
Proc Natl Acad Sci U S A. 2017 May 9;114(19):4993-4998
pubmed: 28446615
Immune Netw. 2020 Feb 10;20(1):e8
pubmed: 32158596

Auteurs

Eleni Gkika (E)

Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, Freiburg, Germany.
German Cancer Consortium (DKTK), Partner Site Freiburg, German Cancer Research Center, Heidelberg, Germany.

Elke Firat (E)

Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, Freiburg, Germany.
German Cancer Consortium (DKTK), Partner Site Freiburg, German Cancer Research Center, Heidelberg, Germany.

Sonja Adebahr (S)

Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, Freiburg, Germany.
German Cancer Consortium (DKTK), Partner Site Freiburg, German Cancer Research Center, Heidelberg, Germany.

Erika Graf (E)

Institute of Medical Biometry and Statistics, Medical Center-University of Freiburg, Faculty of Medicine, Freiburg, Germany.

Ilinca Popp (I)

Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, Freiburg, Germany.
German Cancer Consortium (DKTK), Partner Site Freiburg, German Cancer Research Center, Heidelberg, Germany.

Gianluca Radicioni (G)

Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, Freiburg, Germany.
German Cancer Consortium (DKTK), Partner Site Freiburg, German Cancer Research Center, Heidelberg, Germany.

Simon S Lo (SS)

Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, USA.

Ursula Nestle (U)

Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Department of Radiation Oncology, Kliniken Maria Hilf, Monchengladbach, Germany.

Nils H Nicolay (NH)

Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, Freiburg, Germany.
German Cancer Consortium (DKTK), Partner Site Freiburg, German Cancer Research Center, Heidelberg, Germany.

Gabriele Niedermann (G)

Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, Freiburg, Germany.
German Cancer Consortium (DKTK), Partner Site Freiburg, German Cancer Research Center, Heidelberg, Germany.

Dan G Duda (DG)

E. L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. duda@steele.mgh.harvard.edu.

Anca-L Grosu (AL)

Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, Freiburg, Germany.
German Cancer Consortium (DKTK), Partner Site Freiburg, German Cancer Research Center, Heidelberg, Germany.

Classifications MeSH